Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CareCloud, Inc. stock logo
CCLD
CareCloud
$2.16
+0.9%
$1.73
$1.14
$4.84
$91.41M2.05375,235 shs208,821 shs
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
$13.50
+0.7%
$12.24
$8.50
$23.00
$84.40MN/A37,647 shs3,522 shs
Pliant Therapeutics, Inc. stock logo
PLRX
Pliant Therapeutics
$1.61
-3.0%
$1.42
$1.10
$16.10
$98.83M1.351.12 million shs947,819 shs
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
$0.15
$0.15
$0.12
$0.18
$21.42M2.568,250 shsN/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CareCloud, Inc. stock logo
CCLD
CareCloud
+0.93%+1.89%+0.89%+30.12%-32.29%
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
0.00%-3.57%+24.42%-6.44%+1,349,999,900.00%
Pliant Therapeutics, Inc. stock logo
PLRX
Pliant Therapeutics
-3.01%+17.52%+12.59%-0.62%-86.69%
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
0.00%0.00%0.00%0.00%+13,536.36%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CareCloud, Inc. stock logo
CCLD
CareCloud
3.0623 of 5 stars
2.25.00.00.03.30.82.5
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Pliant Therapeutics, Inc. stock logo
PLRX
Pliant Therapeutics
3.6211 of 5 stars
3.03.00.04.70.61.70.6
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CareCloud, Inc. stock logo
CCLD
CareCloud
2.33
Hold$2.5015.74% Upside
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
0.00
N/AN/AN/A
Pliant Therapeutics, Inc. stock logo
PLRX
Pliant Therapeutics
2.00
Hold$13.31726.86% Upside
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest TRXDW, CCLD, PLRX, and IZTC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/6/2025
CareCloud, Inc. stock logo
CCLD
CareCloud
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
3/18/2025
Pliant Therapeutics, Inc. stock logo
PLRX
Pliant Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
3/14/2025
CareCloud, Inc. stock logo
CCLD
CareCloud
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$3.50 ➝ $1.50
3/13/2025
CareCloud, Inc. stock logo
CCLD
CareCloud
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$1.50
(Data available from 6/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CareCloud, Inc. stock logo
CCLD
CareCloud
$112.51M0.81$0.38 per share5.76$2.63 per share0.82
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
N/AN/AN/AN/AN/AN/A
Pliant Therapeutics, Inc. stock logo
PLRX
Pliant Therapeutics
$1.58M62.55N/AN/A$7.91 per share0.20
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
$8.53M2.51$0.11 per share1.40$2.68 per share0.06
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CareCloud, Inc. stock logo
CCLD
CareCloud
-$48.67M-$0.22N/A2.57N/A-35.25%-87.98%-50.79%8/12/2025 (Estimated)
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
N/AN/A0.00N/AN/AN/AN/AN/A
Pliant Therapeutics, Inc. stock logo
PLRX
Pliant Therapeutics
-$161.34M-$3.61N/AN/AN/AN/A-48.91%-41.09%8/6/2025 (Estimated)
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
-$154.20M-$4.22N/AN/AN/A-2,149.15%-83.74%-64.94%N/A

Latest TRXDW, CCLD, PLRX, and IZTC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2025Q1 2025
CareCloud, Inc. stock logo
CCLD
CareCloud
$0.09$0.05-$0.04-$0.04$25.94 million$27.60 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CareCloud, Inc. stock logo
CCLD
CareCloud
N/AN/AN/AN/AN/A
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
N/AN/AN/AN/AN/A
Pliant Therapeutics, Inc. stock logo
PLRX
Pliant Therapeutics
N/AN/AN/AN/AN/A
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CareCloud, Inc. stock logo
CCLD
CareCloud
N/A
1.03
1.01
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
N/AN/AN/A
Pliant Therapeutics, Inc. stock logo
PLRX
Pliant Therapeutics
0.09
10.26
10.26
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
0.04
3.24
2.30

Institutional Ownership

CompanyInstitutional Ownership
CareCloud, Inc. stock logo
CCLD
CareCloud
10.16%
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
N/A
Pliant Therapeutics, Inc. stock logo
PLRX
Pliant Therapeutics
97.30%
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
8.22%

Insider Ownership

CompanyInsider Ownership
CareCloud, Inc. stock logo
CCLD
CareCloud
14.70%
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
N/A
Pliant Therapeutics, Inc. stock logo
PLRX
Pliant Therapeutics
8.00%
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
3.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
CareCloud, Inc. stock logo
CCLD
CareCloud
4,10042.32 million10.01 millionOptionable
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
N/A6.25 millionN/AN/A
Pliant Therapeutics, Inc. stock logo
PLRX
Pliant Therapeutics
9061.39 million56.96 millionOptionable
TransEnterix, Inc. stock logo
TRXDW
TransEnterix
N/A142.78 millionN/ANot Optionable

Recent News About These Companies

Life Science Partners L P Synergy's Net Worth
Asensus Surgical Inc (ASXC)
TransEnterix, Inc. (TRXDW)
Surgical Robots Global Market Report 2023
Asensus Surgical (NYSEMKT: ASXC)

New MarketBeat Followers Over Time

Media Sentiment Over Time

CareCloud stock logo

CareCloud NASDAQ:CCLD

$2.16 +0.02 (+0.93%)
Closing price 06/5/2025 04:00 PM Eastern
Extended Trading
$2.16 0.00 (0.00%)
As of 06/5/2025 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services. Its technology-enabled business solutions comprise revenue cycle management services, healthcare claims clearinghouse, and medical coding and credentialing services; electronic health records, practice management software and related capabilities, patient experience management solutions, business intelligence and healthcare analytics platforms, and customized applications, interfaces, and various other technology solutions, as well as artificial intelligence, such as CareCloud cirrusAI, AI-powered clinical decision support, AI-powered virtual support assistant, AI-driven appeals, and CareCloud cirrusAI. In addition, the company provides chronic care management, remote patient monitoring, and telemedicine solutions; and professional and consulting services, workforce augmentation and on-demand staffing, and strategic advisory services. Further, it offers medical practice management services to medical practices comprising appropriate facilities, equipment, supplies, support services, nurses, and administrative support staff, as well as management, bill-paying, and financial advisory services. It serves physicians, nurses, nurse practitioners, physician assistants, and other clinicians that render bills for their services. The company was formerly known as MTBC, Inc. and changed its name to CareCloud, Inc. in March 2021. CareCloud, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.

Invizyne Technologies stock logo

Invizyne Technologies NASDAQ:IZTC

$13.50 +0.10 (+0.75%)
As of 06/2/2025

Invizyne Technologies Inc. is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc. is based in Monrovia, CA.

Pliant Therapeutics stock logo

Pliant Therapeutics NASDAQ:PLRX

$1.61 -0.05 (-3.01%)
Closing price 06/5/2025 04:00 PM Eastern
Extended Trading
$1.62 +0.00 (+0.31%)
As of 06/5/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.

TransEnterix stock logo

TransEnterix OTCMKTS:TRXDW

$0.15 0.00 (0.00%)
As of 03/7/2025

TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.